Introduction
Though rare, long term use of phenytoin has been associated with various lymphatic system disorders like pseudolymphoma, Hodgkin lymphoma and non Hodgkin lymphoma. 1 Histopathological changes in phenytoin induced lymphadenopathy may be heterogenous and non specific as well. 2 Phenytoin induced pseudo lymphoma syndrome may show histopathological findings similar to mycosis fungoides and may take a prolonged course even after the cessation of the drug. 3 This case report is about the development of granulomatous lymphadenopathy secondary to long term use of phenytoin, which regressed completely after discontinuation of the drug. The case is being reported because granulomatous pathology may lead to misdiagnosis and management issues if not correlated with phenytoin therapy in such instances.
Case report
59-Year-old female patient was admitted with one episode of generalized convulsions. She was diagnosed to have epilepsy 7 years back and was taking phenytoin sodium 300 mg per day. She discontinued medical follow up for seizures and continued to take the drug. She was admitted with the history of seizures and at that time noticed to have swellings in the sub-mandibular region bilaterally measuring about 3 cm Â 3 cm. Her relatives have noticed the swelling for the past 4 years and had not taken any treatment for the same (Fig. 1 ). There was no fever, significant weight loss or other constitutional symptoms. She did not give history of any major illness in the past except for seizures and a traumatic fracture of the femur. There was no history of tuberculosis in her family. A blood examination revealed no abnormality in cell counts, peripheral smear; liver and renal function tests and serum calcium levels. A chest X-ray revealed mediastinal widening possibly secondary to hilar adenopathy. Ultrasound abdomen did not reveal any organomegaly or paraaortic lymphnode enlargement .The tuberculin test was negative. An open biopsy of the submandibular node was performed. Phenytoin sodium was replaced by oxcarbamazepine. She was not given any antibiotics, steroids or antituberculous therapy. The lady was discharged, and reviewed after 2 weeks. The submandibular lymph nodes showed significant reduction in size, and they completely disappeared over a period of six weeks .The histopathological report showed (Fig. 2) replacement of normal lymph node architecture by multiple coalescent granulomas composed of epitheloid histiocytes with scattered multinucleated giant cells. No definite evidence of caseous necrosis was seen. She was followed up for 6 months and never had recurrence of lymphadenopathy. The chest X-ray also became normal on follow up.
Discussion
Though there are several types of histological features described in the literature associated with phenytoin induced lymphadenopathy, granulomatous adenopathy mimicking tuberculosis is rare. This patient never received antituberculous treatment or steroids, but the lymphadenopathy subsided completely on stopping the phenytoin, which also indicates the role of phenytoin in producing this pathology. Immunohistological studies for lymphoma were not carried out due to financial constraints and the patient became symptom free after stopping phenytoin.
One study which described histopathology of 25 cases of phenytoin induced lymphadenopathy summarizes their results as follows: 15 of 25 cases showed a benign histology, which were classified according to the presence or absence of immunoblastic hyperplasia.
2 Seven cases were non-Hodgkin lymphoma, and three were Hodgkin disease. In two of the five cases for which sequential biopsies were available for review, histology had progressed from paracortical hyperplasia to malignant lymphoma. 2 There are several reports of phenytoin induced appearances of cutaneous dermal infiltrate. The cutaneous nodules resolved within 2 weeks after discontinuation of phenytoin therapy. Phenytoin induced hypersensitivity syndrome can also develop in some cases which were characterized by the development of fever, rash, lymphadenopathy, and hepatitis associated with leukocytosis and eosinophilia. 4 Pseudo lymphoma syndrome (PLS), another important side effect of phenytoin is relatively rare but can lead to death if there are extensive skin lesions, severe hepatitis, agranulocytosis and neutropenia. 5, 6 PLS may also give rise to harmful effects if misdiagnosed as malignant lymphoma.
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This can also occur with other drugs like, phenobarbitone and carbamazepine. Histopathologic features of PLS can mimic mycosis fungoids. 7 During the acute phase of the phenytoin induced pseudolymphoma syndrome, the patient appears immunologically depressed.
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